Recruiting NA INTERVENTIONAL 2-arm NCT06132776

The Mamma HiToP Study

High Tone Therapy for Chemotherapy-induced Neuropathy in Breast Cancer Patients

Sponsor: Vienna Hospital Association

Conditions Chemotherapy-induced Peripheral Neuropathy

Interventions HiToP 191 PNP Placebo device

Updated 4 times since 2023 Last updated: Apr 24, 2024 Started: Nov 3, 2023 Primary completion: Nov 2, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06132776, this NA trial focuses on Chemotherapy-induced Peripheral Neuropathy and remains actively recruiting participants. Sponsored by Vienna Hospital Association, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA
Dec 2023 — May 2024 [monthly]

Recruiting NA

First recorded

Nov 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vienna Hospital Association

Data source: Vienna Hospital Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria